In contrast, De Oliveira Titz et al. (2016) observed no significant differences in serum MMP-2 or TIMP levels, although baseline concentrations of TIMP-1 and TIMP-2 were reduced in cultured eosinophils from AD patients [86]. This evidence concerns the gene TIMP2 and Alzheimer disease.